Moderate Drug Interaction

Can You Take Oxycodone with Amitriptyline?

Understanding the moderate interaction between Oxycodone (Oxycodone BNM) and Amitriptyline (ENTRIP) for claims professionals, support workers, and care managers.

Moderate severity AllMeds interaction database Updated April 2026

Combining Oxycodone (Oxycodone BNM) with Amitriptyline (ENTRIP) is a moderate interaction requiring caution and monitoring. Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.

Key Takeaways

  • Interaction severity: Moderate
  • Risk: Serotonin syndrome (agitation, hyperthermia, rigidity), excessive sedation.
  • Mechanism: Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
  • Oxycodone: S8 in Australia, high risk
  • Amitriptyline: S4 in Australia, moderate risk
  • Claims action: Monitor and document. Request clinical justification if combination is ongoing.

Oxycodone vs Amitriptyline at a Glance

Property Oxycodone Amitriptyline
Brand names Oxycodone BNM, OxyNorm, Oxycodone Sandoz ENTRIP, Amitriptyline Lupin, APX-Amitriptyline
Drug class opioid antidepressant
Risk level high moderate
TGA Schedule (AU) S8 S4

Why Is This Combination Dangerous?

Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.

Clinical risk: Serotonin syndrome (agitation, hyperthermia, rigidity), excessive sedation.

Regulatory Guidance by Jurisdiction

Australia TGA / SIRA / WorkSafe

The TGA and Australian Medicines Handbook classify this as a moderate drug interaction requiring monitoring and clinical review.

United Kingdom NICE / MHRA / FPM

NICE guidelines advise against combining multiple serotonergic medications due to the risk of serotonin syndrome. For personal injury claims, antidepressant prescribing should be reviewed for injury relatedness and appropriateness.

United States FDA / CDC / State WC

The FDA has issued Drug Safety Communications about the risk of serotonin syndrome with concurrent use of serotonergic medications. Workers compensation nurse case managers should flag this combination for prescriber review.

What Claims Professionals Should Do

  1. Document the combination in the claim file with a note on interaction risk
  2. Request clinical justification from the prescriber at the next review
  3. Monitor for adverse effects including excessive sedation, falls, and cognitive impairment
  4. Assess injury relatedness of both medications to the compensable condition
  5. Review at next claim assessment and consider whether the combination is still clinically appropriate

Need to assess this medication across your caseload?

Check all interactions for Oxycodone and Amitriptyline across your claimant's full medication list.

AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.

Book a Demo

Free trial available. No credit card required.

Related Resources

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.